{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:29Z","timestamp":1761102269047,"version":"3.41.2"},"reference-count":68,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2017.00077","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T04:02:21Z","timestamp":1492574541000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Emerging Therapies for Childhood Polycystic Kidney Disease"],"prefix":"10.3389","volume":"5","author":[{"suffix":"Jr","given":"William E.","family":"Sweeney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellis D.","family":"Avner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.gastro.2012.09.056","article-title":"Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease","volume":"144","author":"Gunay-Aygun","year":"2013","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/978-3-662-43596-0_32","article-title":"Childhood polycystic kidney disease","volume-title":"Pediatric Nephrology","author":"Sweeney","year":"2016"},{"key":"B3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu Rev Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0888-7543(95)80020-M","article-title":"Evidence for a third genetic locus for autosomal dominant polycystic kidney disease","volume":"25","author":"Daoust","year":"1995","journal-title":"Genomics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00214191","article-title":"Autosomal dominant polycystic kidney disease: evidence for the existence of a third locus in a Portuguese family","volume":"96","author":"De Almeida","year":"1995","journal-title":"Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0272-6386(96)90261-9","article-title":"An Italian family with autosomal dominant polycystic kidney disease unlinked to either the PKD1 or PKD2 gene","volume":"28","author":"Turco","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase IIalpha subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00467-010-1656-1","article-title":"Diagnosis and management of childhood polycystic kidney disease","volume":"26","author":"Sweeney","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2215\/CJN.00550110","article-title":"Evidence of extraordinary growth in the progressive enlargement of renal cysts","volume":"5","author":"Grantham","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","article-title":"Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells","volume":"66","author":"Belibi","year":"2004","journal-title":"Kidney Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2215\/CJN.06300615","article-title":"Effect of tolvaptan in autosomal dominant polycystic kidney disease by CKD stage: results from the TEMPO 3:4 trial","volume":"11","author":"Torres","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"C487","DOI":"10.1152\/ajpcell.1995.269.2.C487","article-title":"Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD","volume":"269","author":"Du","year":"1995","journal-title":"Am J Physiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ki.1995.62","article-title":"Epidermal growth factor receptor expression is abnormal in murine polycystic kidney","volume":"47","author":"Orellana","year":"1995","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/ki.1995.118","article-title":"Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture","volume":"47","author":"Pugh","year":"1995","journal-title":"Kidney Int"},{"key":"B20","first-page":"F387","article-title":"Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease","volume":"275","author":"Sweeney","year":"1998","journal-title":"Am J Physiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1046\/j.1523-1755.2003.00232.x","article-title":"Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability","volume":"64","author":"Sweeney","year":"2003","journal-title":"Kidney Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1172\/JCI2071","article-title":"Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease","volume":"101","author":"Richards","year":"1998","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1046\/j.1523-1755.2001.00963.x","article-title":"A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease","volume":"60","author":"Dell","year":"2001","journal-title":"Kidney Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00109-012-0902-3","article-title":"Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation","volume":"90","author":"Aguiari","year":"2012","journal-title":"J Mol Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"F577","DOI":"10.1152\/ajprenal.00607.2016","article-title":"Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression","volume":"312","author":"Streets","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1038\/sj.onc.1208159","article-title":"Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis","volume":"23","author":"Silva","year":"2004","journal-title":"Oncogene"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1681\/ASN.2013091026","article-title":"The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation","volume":"25","author":"Talbot","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.1073\/pnas.1103816108","article-title":"Polycystin-1 regulates STAT activity by a dual mechanism","volume":"108","author":"Talbot","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2215\/CJN.05611207","article-title":"Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease","volume":"3","author":"Edelstein","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1093\/ndt\/gfp129","article-title":"Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)","volume":"24","author":"Zafar","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ng.860","article-title":"A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation","volume":"43","author":"Fedeles","year":"2011","journal-title":"Nat Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1097\/01.ASN.0000141055.57643.E0","article-title":"Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease","volume":"15","author":"Pazour","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1076","article-title":"Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells","volume":"33","author":"Nauli","year":"2003","journal-title":"Nat Genet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1681\/ASN.2005080830","article-title":"Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction","volume":"17","author":"Nauli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","article-title":"Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease","volume":"45","author":"Ma","year":"2013","journal-title":"Nat Genet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.krcp.2014.05.002","article-title":"Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease","volume":"33","author":"Lee","year":"2014","journal-title":"Kidney Res Clin Pract"},{"key":"B44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature17426","article-title":"Primary cilia are not calcium-responsive mechanosensors","volume":"531","author":"Delling","year":"2016","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum Mol Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.ackd.2010.01.002","article-title":"Molecular advances in autosomal dominant polycystic kidney disease","volume":"17","author":"Gallagher","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity","volume":"122","author":"Hopp","year":"2012","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molmed.2014.01.004","article-title":"Polycystin-1: a master regulator of intersecting cystic pathways","volume":"20","author":"Fedeles","year":"2014","journal-title":"Trends Mol Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1681\/ASN.2013080864","article-title":"Variable cyst development in autosomal dominant polycystic kidney disease: the biologic context","volume":"26","author":"Leonhard","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/hmg\/ddh336","article-title":"Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease","volume":"13","author":"Lantinga-van Leeuwen","year":"2004","journal-title":"Hum Mol Genet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1681\/ASN.2006121387","article-title":"Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/ki.2011.370","article-title":"A missense mutation in PKD1 attenuates the severity of renal disease","volume":"81","author":"Pei","year":"2012","journal-title":"Kidney Int"},{"key":"B53","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/cge.12383","article-title":"Autosomal dominant polycystic kidney disease caused by somatic and germline mosaicism","volume":"87","author":"Tan","year":"2014","journal-title":"Clin Genet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ki.2011.296","article-title":"Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation","volume":"81","author":"Fan","year":"2012","journal-title":"Kidney Int"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e49418","DOI":"10.1371\/journal.pone.0049418","article-title":"HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/hmg\/ddt556","article-title":"SIRT2 regulates ciliogenesis and contributes to abnormal centrosome amplification caused by loss of polycystin-1","volume":"23","author":"Zhou","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1003053","DOI":"10.1371\/journal.pgen.1003053","article-title":"Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4alpha as a disease modifier","volume":"8","author":"Menezes","year":"2012","journal-title":"PLoS Genet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1681\/ASN.2010101080","article-title":"Mutations in multiple PKD genes may explain early and severe polycystic kidney disease","volume":"22","author":"Bergmann","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-013-2706-2","article-title":"ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies","volume":"30","author":"Bergmann","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease \u2013 a contiguous gene syndrome","volume":"8","author":"Brook-Carter","year":"1994","journal-title":"Nat Genet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00109-014-1185-7","article-title":"Intragenic motifs regulate the transcriptional complexity of Pkhd1\/PKHD1","volume":"92","author":"Boddu","year":"2014","journal-title":"J Mol Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10815-010-9432-5","article-title":"Birth of a healthy infant following preimplantation PKHD1 haplotyping for autosomal recessive polycystic kidney disease using multiple displacement amplification","volume":"27","author":"Lau","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1158\/1078-0432.CCR-06-2590","article-title":"Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647","volume":"13","author":"Gendreau","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/1078-0432.CCR-07-4367","article-title":"EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation","volume":"14","author":"Trowe","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1681\/ASN.2012040367","article-title":"Folate-conjugated rapamycin slows progression of polycystic kidney disease","volume":"23","author":"Shillingford","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2215\/CJN.09941014","article-title":"Urinary EGF receptor ligand excretion in patients with autosomal dominant polycystic kidney disease and response to tolvaptan","volume":"10","author":"Harskamp","year":"2015","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00077\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T16:31:44Z","timestamp":1658939504000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00077\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":68,"alternative-id":["10.3389\/fped.2017.00077"],"URL":"https:\/\/doi.org\/10.3389\/fped.2017.00077","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2017,4,19]]},"article-number":"77"}}